We are analyzing https://link.springer.com/article/10.1007/s11010-015-2435-x.

Title:
Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat | Molecular and Cellular Biochemistry
Description:
Left ventricular hypertrophy (LVH) is an independent risk factor for cardiac failure. Reduction of LVH has beneficial effects on the heart. LVH is associated with shift in energy substrate preference from fatty acid to glucose, mediated by down regulation of peroxisome proliferator-activated receptor-alpha (PPAR-α). As long-term dependence on glucose can promote adverse cardiac remodeling, it was hypothesized that, prevention of metabolic shift by averting down regulation of PPAR-α can reduce cardiac remodeling in spontaneously hypertensive rat (SHR). Cardiac response to stimulation of PPAR-α presumably depends on the type of ligand used. Therefore, the study was carried out in SHR, using two different PPAR-α ligands. SHR were treated with either fenofibrate (100 mg/kg/day) or medium-chain triglyceride (MCT) Tricaprylin (5 % of diet) for 4 months. Expression of PPAR-α and medium-chain acylCoA dehydrogenase served as markers, for stimulation of PPAR-α. Both ligands stimulated PPAR-α. Decrease of blood pressure was observed only with fenofibrate. LVH was assessed from heart-weight/body weight ratio, histology and brain natriuretic peptide expression. As oxidative stress is linked with hypertrophy, serum and cardiac malondialdehyde and cardiac 3-nitrotyrosine levels were determined. Compared to untreated SHR, LVH and oxidative stress were lower on supplementation with MCT, but higher on treatment with fenofibrate. The observations indicate that reduction of blood pressure is not essentially accompanied by reduction of LVH, and that, progressive cardiac remodeling can be prevented with decrease in oxidative stress. Contrary to the notion that reactivation of PPAR-α is detrimental; the study substantiates that cardiac response to stimulation of PPAR-α is ligand specific.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

article, pubmed, google, scholar, cas, cardiac, heart, fenofibrate, rat, hypertrophy, peroxisome, proliferatoractivated, hypertensive, cell, spontaneously, pparα, mol, physiol, fatty, stress, hypertension, left, remodeling, oxidative, research, response, stimulation, receptoralpha, nair, ventricular, acid, metabolic, mediumchain, myocardial, central, alpha, purushothaman, lvh, failure, effects, blood, pressure, access, receptor, cardiol, pparalpha, rats, privacy, cookies, function,

Topics {✒️}

peroxisome proliferator-activated receptor-alpha peroxisome-proliferator-activated receptor alpha peroxisome proliferator-activated receptor-α peroxisome proliferator-activated receptor heart-weight/body weight ratio plant-derived fat high-fat feeding month download article/chapter porcine tachycardia-induced cardiomyopathy medium-chain fatty acids angiotensin ii-dependent hypertension medium-chain triglyceride therapy redox-regulated transcription factors medium-chain fatty acid real-time quantitative pcr preventing p65-nfκb binding pressure-overloaded rat hearts angiotensin ii-infused rats pparalpha activator fenofibrate medium-chain triglyceride normotensive wistar-kyoto rats ligands stimulated ppar-α related subjects laboratory animal sciences ligand specific variation blood pressure-independent attenuation left ventricular hypertrophy full article pdf fenofibrate prevents aldosterone-induced hypertension left ventricular mass ppar-alpha agonists left ventricular dysfunction privacy choices/manage cookies h1425–h1436 cellular biochemistry aims ppar-α ligands ppar-alpha agonist long-term dependence cardiac hypertrophic growth reduce cardiac remodeling progressive cardiac remodeling attenuates cardiac fibrosis senior research fellowship fatty acid oxidation article ismael spontaneously hypertensive rat hypertrophied rat heart independent risk factor article molecular

Questions {❓}

Tanaka T, Sohmiya K, Kawamura K (1997) Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat
         description:Left ventricular hypertrophy (LVH) is an independent risk factor for cardiac failure. Reduction of LVH has beneficial effects on the heart. LVH is associated with shift in energy substrate preference from fatty acid to glucose, mediated by down regulation of peroxisome proliferator-activated receptor-alpha (PPAR-α). As long-term dependence on glucose can promote adverse cardiac remodeling, it was hypothesized that, prevention of metabolic shift by averting down regulation of PPAR-α can reduce cardiac remodeling in spontaneously hypertensive rat (SHR). Cardiac response to stimulation of PPAR-α presumably depends on the type of ligand used. Therefore, the study was carried out in SHR, using two different PPAR-α ligands. SHR were treated with either fenofibrate (100 mg/kg/day) or medium-chain triglyceride (MCT) Tricaprylin (5 % of diet) for 4 months. Expression of PPAR-α and medium-chain acylCoA dehydrogenase served as markers, for stimulation of PPAR-α. Both ligands stimulated PPAR-α. Decrease of blood pressure was observed only with fenofibrate. LVH was assessed from heart-weight/body weight ratio, histology and brain natriuretic peptide expression. As oxidative stress is linked with hypertrophy, serum and cardiac malondialdehyde and cardiac 3-nitrotyrosine levels were determined. Compared to untreated SHR, LVH and oxidative stress were lower on supplementation with MCT, but higher on treatment with fenofibrate. The observations indicate that reduction of blood pressure is not essentially accompanied by reduction of LVH, and that, progressive cardiac remodeling can be prevented with decrease in oxidative stress. Contrary to the notion that reactivation of PPAR-α is detrimental; the study substantiates that cardiac response to stimulation of PPAR-α is ligand specific.
         datePublished:2015-05-15T00:00:00Z
         dateModified:2015-05-15T00:00:00Z
         pageStart:173
         pageEnd:182
         sameAs:https://doi.org/10.1007/s11010-015-2435-x
         keywords:
            Cardiac remodeling
            Metabolic shift
            Stimulation of PPAR-α
            Fenofibrate
            Medium chain triglyceride
            Oxidative stress
            Biochemistry
            general
            Cardiology
            Cancer Research
            Medical Biochemistry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig7_HTML.gif
         isPartOf:
            name:Molecular and Cellular Biochemistry
            issn:
               1573-4919
               0300-8177
            volumeNumber:406
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Saifudeen Ismael
               affiliation:
                     name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
                     address:
                        name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sreeja Purushothaman
               affiliation:
                     name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
                     address:
                        name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:V. S. Harikrishnan
               affiliation:
                     name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
                     address:
                        name:Division of Laboratory Animal Sciences, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Renuka Nair
               affiliation:
                     name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
                     address:
                        name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat
      description:Left ventricular hypertrophy (LVH) is an independent risk factor for cardiac failure. Reduction of LVH has beneficial effects on the heart. LVH is associated with shift in energy substrate preference from fatty acid to glucose, mediated by down regulation of peroxisome proliferator-activated receptor-alpha (PPAR-α). As long-term dependence on glucose can promote adverse cardiac remodeling, it was hypothesized that, prevention of metabolic shift by averting down regulation of PPAR-α can reduce cardiac remodeling in spontaneously hypertensive rat (SHR). Cardiac response to stimulation of PPAR-α presumably depends on the type of ligand used. Therefore, the study was carried out in SHR, using two different PPAR-α ligands. SHR were treated with either fenofibrate (100 mg/kg/day) or medium-chain triglyceride (MCT) Tricaprylin (5 % of diet) for 4 months. Expression of PPAR-α and medium-chain acylCoA dehydrogenase served as markers, for stimulation of PPAR-α. Both ligands stimulated PPAR-α. Decrease of blood pressure was observed only with fenofibrate. LVH was assessed from heart-weight/body weight ratio, histology and brain natriuretic peptide expression. As oxidative stress is linked with hypertrophy, serum and cardiac malondialdehyde and cardiac 3-nitrotyrosine levels were determined. Compared to untreated SHR, LVH and oxidative stress were lower on supplementation with MCT, but higher on treatment with fenofibrate. The observations indicate that reduction of blood pressure is not essentially accompanied by reduction of LVH, and that, progressive cardiac remodeling can be prevented with decrease in oxidative stress. Contrary to the notion that reactivation of PPAR-α is detrimental; the study substantiates that cardiac response to stimulation of PPAR-α is ligand specific.
      datePublished:2015-05-15T00:00:00Z
      dateModified:2015-05-15T00:00:00Z
      pageStart:173
      pageEnd:182
      sameAs:https://doi.org/10.1007/s11010-015-2435-x
      keywords:
         Cardiac remodeling
         Metabolic shift
         Stimulation of PPAR-α
         Fenofibrate
         Medium chain triglyceride
         Oxidative stress
         Biochemistry
         general
         Cardiology
         Cancer Research
         Medical Biochemistry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-015-2435-x/MediaObjects/11010_2015_2435_Fig7_HTML.gif
      isPartOf:
         name:Molecular and Cellular Biochemistry
         issn:
            1573-4919
            0300-8177
         volumeNumber:406
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Saifudeen Ismael
            affiliation:
                  name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
                  address:
                     name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sreeja Purushothaman
            affiliation:
                  name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
                  address:
                     name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:V. S. Harikrishnan
            affiliation:
                  name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
                  address:
                     name:Division of Laboratory Animal Sciences, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Renuka Nair
            affiliation:
                  name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
                  address:
                     name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular and Cellular Biochemistry
      issn:
         1573-4919
         0300-8177
      volumeNumber:406
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
      address:
         name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
         type:PostalAddress
      name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
      address:
         name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
         type:PostalAddress
      name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
      address:
         name:Division of Laboratory Animal Sciences, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
         type:PostalAddress
      name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
      address:
         name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Saifudeen Ismael
      affiliation:
            name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
            address:
               name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
               type:PostalAddress
            type:Organization
      name:Sreeja Purushothaman
      affiliation:
            name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
            address:
               name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
               type:PostalAddress
            type:Organization
      name:V. S. Harikrishnan
      affiliation:
            name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
            address:
               name:Division of Laboratory Animal Sciences, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
               type:PostalAddress
            type:Organization
      name:R. Renuka Nair
      affiliation:
            name:Sree Chitra Tirunal Institute for Medical Sciences and Technology
            address:
               name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
      name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
      name:Division of Laboratory Animal Sciences, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
      name:Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(205)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.98s.

LINK . SPRINGER . COM {}